Obicetrapib and ezetimibe combination therapy lowers LDL cholesterol in high-risk patients
1. FDC obicetrapib plus ezetimibe significantly decreased LDL cholesterol levels by 48.6% compared to placebo. 2. Serious adverse events were ...
Tag: ezetimibe
Moderate-intensity statin plus ezetimibe is non-inferior to high-intensity statin monotherapy
1. 3-year composite outcome of stroke and cardiovascular disease was comparable between both groups (9.1% combination vs. 9.9% monotherapy). 2. ...
#VisualAbstract: A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke
1. This randomized controlled trial showed that patients with ischemic stroke or transient ischemic attack with target LDL levels of ...
Lower LDL cholesterol level after ischemic stroke decreases risk of subsequent stroke
1. This randomized controlled trial showed that patients with ischemic stroke or transient ischemic attack with target LDL levels of ...